Keiji Saito

USPTO Granted Patents = 25 (Patent Applications = 7)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Tokyo, JP (2014 - 2024)
Atsugi, JP (2020 - 2024)

Company Filing History:

13 out of 440

Daiichi Sankyo Company, Limited

The Furukawa Electric Co., Ltd.

patents

4. 1 out of 308

Kayaba Industry Company, Ltd.

where one patent can have more than one assignee

Years Active: 2014-2025

where 'Filed Patents' based on already Granted Patents

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12297187 - Compound having cyclic structure (2025-05-13),

2. 12091395 - Griseofulvin compound (2024-09-17),

3. 11993593 - Griseofulvin compound and pharmaceutical use thereof (2024-05-28),

4. 11981686 - Urea compound having substituent (2024-05-14),

5. 11834427 - Griseofulvin compound (2023-12-05),

6. 11512067 - Compound having cyclic structure (2022-11-29),

7. 11472784 - Griseofulvin compound (2022-10-18),

8. 11407746 - Griseofulvin compound and pharmaceutical use thereof (2022-08-09),

9. 10975052 - Griseofulvin compound (2021-04-13),

10. 10947289 - Glyco-modified atrial natriuretic peptide (2021-03-16),

11. 10654821 - Griseofulvin compound (2020-05-19),

12. 10570109 - Griseofulvin compound (2020-02-25),

13. 10079360 - Resin composition for sealing electronic devices, and electronic device (2018-09-18),

14. 10043996 - Resin composition for element encapsulation for organic electronic devices, resin sheet for element encapsulation for organic electronic devices, organic electroluminescent element, and image display device (2018-08-07),

15. 9797465 - Magnetorheological fluid shock absorber (2017-10-24),

Title: Keiji Saito: Pioneering Innovations in Tokyo, JP

Introduction: Keiji Saito is a prominent inventor based in Tokyo, JP, with a remarkable track record of transforming groundbreaking ideas into practical solutions. His unwavering dedication to pushing the boundaries of technology has positioned him as a trailblazer in the global innovation landscape.

Latest Patents: Keiji Saito recently secured two innovative patents that underscore his commitment to addressing significant challenges in healthcare. The first patent revolves around a Griseofulvin compound and its pharmaceutical applications for central inflammatory diseases. The compound, outlined by a specific chemical formula, offers a promising solution for prophylaxis and treatment in this critical medical area. The second patent focuses on a urea compound with a unique structure that activates SIRT6, showing potential as a key component in battling inflammatory diseases.

Career Highlights: Throughout his illustrious career, Keiji Saito has made significant contributions to the field of innovation while working with renowned companies such as Daiichi Sankyo Company, Limited and Kyb Corporation. His expertise and ingenuity have led to the development of groundbreaking solutions that have positively impacted various industries.

Collaborations: Keiji Saito has collaborated with esteemed professionals in his field, including Katsuyoshi Nakajima and Yasuyuki Ogawa. These partnerships have facilitated the exchange of ideas, driving forward innovative projects and fostering a culture of creativity and excellence.

Conclusion: Keiji Saito's legacy as a pioneering inventor is characterized by his relentless pursuit of technological advancements and his profound impact on the global inventor community. His innovative spirit and dedication to addressing pressing societal issues through inventive solutions solidify his position as a visionary leader in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.